OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 104 citing articles:

Dysbiosis of Gut Microbiota Promotes Hepatocellular Carcinoma Progression by Regulating the Immune Response
Nan Zhang, Yusong Gou, Shan Liang, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-13
Open Access | Times Cited: 27

Microbiome and Metabolomics in Liver Cancer: Scientific Technology
Raja Ganesan, Sang Jun Yoon, Ki Tae Suk
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 537-537
Open Access | Times Cited: 21

The Role of Gut Microbiota in Neuropsychiatric Diseases – Creation of An Atlas-Based on Quantified Evidence
Bruno Bonnechère, Najaf Amin, Cornelia M. van Duijn
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 20

Altered Gut Microbiota Composition and Its Potential Association in Patients with Advanced Hepatocellular Carcinoma
Ran Huo, Yanlin Chen, Jie Li, et al.
Current Oncology (2023) Vol. 30, Iss. 2, pp. 1818-1830
Open Access | Times Cited: 12

Microbiome interplays in the gut-liver axis: implications for liver cancer pathogenesis and therapeutic insights
Xuran Wang, Bin Zhang, Runqiu Jiang
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access

Sirtuins and Gut Microbiota: Dynamics in Health and a Journey from Metabolic Dysfunction to Hepatocellular Carcinoma
Mahmoud Zhra, Muhammad Affan Elahi, Aamira Tariq, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 466-466
Open Access

Thomasclavelia ramosa and Alcohol-Related Hepatocellular Carcinoma: A Microbial Culturomics Study
Reham Magdy Wasfy, Anissa Abdoulaye, Patrick BORENTAIN, et al.
Research Square (Research Square) (2025)
Closed Access

Roles of the gut microbiota in hepatocellular carcinoma: from the gut dysbiosis to the intratumoral microbiota
Yiqin Wang, Yongqiang Li, Yong Lin, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access

The human microbiome: redefining cancer pathogenesis and therapy
Yogita K. Adlakha, Ravindresh Chhabra
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access

Therapeutic implications of probiotics in microbiota dysbiosis: A special reference to the liver and oral cancers
Deepti Singh, Mohammad Afsar Khan, Hifzur R. Siddique
Life Sciences (2021) Vol. 285, pp. 120008-120008
Closed Access | Times Cited: 25

The Application of High-Throughput Technologies for the Study of Microbiome and Cancer
Lu Wei, Io Hong Cheong, Guang Yang, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 24

Gut Microbiome and Cancer: From Cancer Development to Therapeutics with a Special Focus on Hepatocellular Carcinoma
Sancharan Acharya, Chinnasamy Thirunavukkarasu
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 2, pp. 67-67
Open Access | Times Cited: 3

The Role of Gut Microbiota in Gastrointestinal Tract Cancers
Marta Grochowska, Karol Perlejewski, Tomasz Laskus, et al.
Archivum Immunologiae et Therapiae Experimentalis (2022) Vol. 70, Iss. 1
Open Access | Times Cited: 16

Altered gut microbiota in hepatocellular carcinoma: Insights into the pathogenic mechanism and preclinical to clinical findings
Bhrigu Kumar Das
Apmis (2022) Vol. 130, Iss. 12, pp. 719-740
Closed Access | Times Cited: 14

Atypical immunometabolism and metabolic reprogramming in liver cancer: Deciphering the role of gut microbiome
Rachel M. Golonka, Matam Vijay‐Kumar
Advances in cancer research (2020), pp. 171-255
Closed Access | Times Cited: 22

Association between gut microbiota and seven gastrointestinal diseases: A Mendelian randomized study
Shuang Jing Zhu, Zhen Ding
The Journal of Gene Medicine (2023) Vol. 26, Iss. 1
Closed Access | Times Cited: 7

Microbiota-Associated Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Cancer: A Review
Yi‐Hsun Chen, Wei‐Kai Wu, Ming–Shiang Wu
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 5999-5999
Open Access | Times Cited: 20

Effect of the Aerobic Denitrifying Bacterium Pseudomonas furukawaii ZS1 on Microbiota Compositions in Grass Carp Culture Water
Wangbao Gong, Shuwei Gao, Yun Zhu, et al.
Water (2021) Vol. 13, Iss. 10, pp. 1329-1329
Open Access | Times Cited: 17

The microbiome, gastrointestinal cancer, and immunotherapy
Rachel C. Newsome, Ye Yang, Christian Jobin
Journal of Gastroenterology and Hepatology (2021) Vol. 37, Iss. 2, pp. 263-272
Open Access | Times Cited: 17

Metabolic syndrome cannot mask the changes of faecal microbiota compositions caused by primary hepatocellular carcinoma
Jiajia Ni, Chenying Fu, Rong Huang, et al.
Letters in Applied Microbiology (2021) Vol. 73, Iss. 1, pp. 73-80
Closed Access | Times Cited: 16

Urinary microbiome-based metagenomic signature for the noninvasive diagnosis of hepatocellular carcinoma
Eun Ju Cho, Boram Kim, Su Jong Yu, et al.
British Journal of Cancer (2024) Vol. 130, Iss. 6, pp. 970-975
Open Access | Times Cited: 2

Gut microbiota differences during metamorphosis in sick and healthy giant spiny frogs ( Paa spinosa ) tadpoles
J. Long, J. Xiang, Tan He, et al.
Letters in Applied Microbiology (2019) Vol. 70, Iss. 2, pp. 109-117
Closed Access | Times Cited: 18

Host–Microbiota Interactions in Liver Inflammation and Cancer
Julie Giraud, Maya Saleh
Cancers (2021) Vol. 13, Iss. 17, pp. 4342-4342
Open Access | Times Cited: 13

Scroll to top